Medline Convenience Kits: 1) DRAWER 9 CRICOTHYROTOMY KIT, Model Number: ACC010741; 2) KIT ANESTHESIA L&D A...
Medline Industries, LP began a recall of Medline Convenience Kits: 1) DRAWER 9 CRICOTHYROTOMY KIT, Model Number: ACC010741; 2) KIT ANESTHESIA L&D A- LINE SET, Model Number: DYKMBNDL199A on . The reason FDA records is "The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-3048-2026
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- MEDLINE INDUSTRIES, LP - Northfield
- Product
- Medline Convenience Kits: 1) DRAWER 9 CRICOTHYROTOMY KIT, Model Number: ACC010741; 2) KIT ANESTHESIA L&D A- LINE SET, Model Number: DYKMBNDL199A
- Product code
- CAI Circuit, Breathing (W Connector, Adaptor, Y Piece)
- Reason for recall
- The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the sterile barrier is compromised, patients and users may be exposed to microbial contamination. Potential health consequences may include no injury, localized infection, or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization. In rare cases, particularly in critically ill or immunocompromised patients, severe infection could become life-threatening.
- Root cause tag
- manufacturing process
- FDA root cause
- Nonconforming Material/Component
- Action
- An URGENT MEDICAL DEVICE RECALL notification letter dated 6/12/25 was sent to customers. REQUIRED ACTION: 1. Immediately check your stock for the affected item number(s) and the affected lot number(s) listed within the recall portal. Quarantine all affected product. 2. Please use the link and the information below to complete your response form. Please list the quantity of affected product you have in inventory on the form. Even if you do not have any affected product in inventory, please complete and submit the form. Website link: https://recalls.medline.com Recall Reference #: R-26-097-FGX1 Recall Code: 3. Upon receipt of your submitted response form, your account will receive over-labels to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. 4. If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please include your customers quantities on your response form. Upon receipt of your submitted response form, you will receive over-labels to provide to your customers to affix to their affected product. If you have any questions, contact the Recall Department at 866-359-1704 or [email protected].
- Quantity in commerce
- 104 kits
- Distribution
- US Nationwide distribution.
- Product codes and lots
- 1) ACC010741, UDI-DI: 10195327515515(each), 40195327515516(case), Lot Number: 23KDB215; 2) DYKMBNDL199A, UDI-DI: 10193489848540(each), 40193489848541(case), Lot Number: 24LBT847; 3) DYKMBNDL199A, UDI-DI: 10193489848540(each), 40193489848541(case), Lot Number: 24LBB138
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-3048-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3049-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3050-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3051-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3052-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3053-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3054-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3055-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3056-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3057-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3058-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3059-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3060-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3061-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3062-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-3063-2026 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
